Spatial control of translation repression and polarized growth by conserved NDR kinase Orb6 and RNA-binding protein Sts5

  1. Illyce Nuñez
  2. Marbelys Rodriguez Pino
  3. David J Wiley
  4. Maitreyi E Das
  5. Chuan Chen
  6. Tetsuya Goshima
  7. Kazunori Kume
  8. Dai Hirata
  9. Takashi Toda
  10. Fulvia Verde  Is a corresponding author
  1. University of Miami School of Medicine, United States
  2. The University of Tennessee, United States
  3. National Research Institute of Brewing, Japan
  4. Hiroshima University, Japan
  5. The Francis Crick Institute, United Kingdom

Abstract

RNA-binding proteins contribute to the formation of ribonucleoprotein (RNP) granules by phase transition, but regulatory mechanisms are not fully understood. Conserved fission yeast NDR (Nuclear Dbf2-Related) kinase Orb6 governs cell morphogenesis in part by spatially controlling Cdc42 GTPase. Here we describe a novel, independent function for Orb6 kinase in negatively regulating the recruitment of RNA-binding protein Sts5 into RNPs to promote polarized cell growth. We find that Orb6 kinase inhibits Sts5 recruitment into granules, its association with processing (P) bodies, and degradation of Sts5-bound mRNAs by promoting Sts5 interaction with 14-3-3 protein Rad24. Many Sts5-bound mRNAs encode essential factors for polarized cell growth, and Orb6 kinase spatially and temporally controls the extent of Sts5 granule formation. Disruption of this control system affects cell morphology and alters the pattern of polarized cell growth, revealing a role for Orb6 kinase in the spatial control of translational repression that enables normal cell morphogenesis.

Article and author information

Author details

  1. Illyce Nuñez

    Molecular and Cellular Pharmacology, University of Miami School of Medicine, Miami, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Marbelys Rodriguez Pino

    Molecular and Cellular Pharmacology, University of Miami School of Medicine, Miami, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. David J Wiley

    Molecular and Cellular Pharmacology, University of Miami School of Medicine, Miami, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Maitreyi E Das

    Department of Biochemistry and Cellular and Molecular Biology, The University of Tennessee, Knoxville, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Chuan Chen

    Molecular and Cellular Pharmacology, University of Miami School of Medicine, Miami, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Tetsuya Goshima

    National Research Institute of Brewing, Higashi-Hiroshima, Japan
    Competing interests
    The authors declare that no competing interests exist.
  7. Kazunori Kume

    Department of Molecular Biotechnology, Hiroshima University, Higashi-Hiroshima, Japan
    Competing interests
    The authors declare that no competing interests exist.
  8. Dai Hirata

    Department of Molecular Biotechnology, Hiroshima University, Higashi-Hiroshima, Japan
    Competing interests
    The authors declare that no competing interests exist.
  9. Takashi Toda

    The Francis Crick Institute, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Fulvia Verde

    Molecular and Cellular Pharmacology, University of Miami School of Medicine, Miami, United States
    For correspondence
    fverde@miami.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2575-0823

Funding

National Institutes of Health (GM095867)

  • Marbelys Rodriguez Pino
  • David J Wiley
  • Maitreyi E Das
  • Chuan Chen
  • Fulvia Verde

National Science Foundation (745129)

  • Maitreyi E Das
  • Fulvia Verde

Cancer Research UK

  • Takashi Toda

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2016, Nuñez et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,158
    views
  • 445
    downloads
  • 23
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Illyce Nuñez
  2. Marbelys Rodriguez Pino
  3. David J Wiley
  4. Maitreyi E Das
  5. Chuan Chen
  6. Tetsuya Goshima
  7. Kazunori Kume
  8. Dai Hirata
  9. Takashi Toda
  10. Fulvia Verde
(2016)
Spatial control of translation repression and polarized growth by conserved NDR kinase Orb6 and RNA-binding protein Sts5
eLife 5:e14216.
https://doi.org/10.7554/eLife.14216

Share this article

https://doi.org/10.7554/eLife.14216

Further reading

    1. Cell Biology
    Yajun Zhai, Peiyi Liu ... Gongzheng Hu
    Research Article

    Discovering new strategies to combat the multidrug-resistant bacteria constitutes a major medical challenge of our time. Previously, artesunate (AS) has been reported to exert antibacterial enhancement activity in combination with β-lactam antibiotics via inhibition of the efflux pump AcrB. However, combination of AS and colistin (COL) revealed a weak synergistic effect against a limited number of strains, and few studies have further explored its possible mechanism of synergistic action. In this article, we found that AS and EDTA could strikingly enhance the antibacterial effects of COL against mcr-1- and mcr-1+ Salmonella strains either in vitro or in vivo, when used in triple combination. The excellent bacteriostatic effect was primarily related to the increased cell membrane damage, accumulation of toxic compounds and inhibition of MCR-1. The potential binding sites of AS to MCR-1 (THR283, SER284, and TYR287) were critical for its inhibition of MCR-1 activity. Additionally, we also demonstrated that the CheA of chemosensory system and virulence-related protein SpvD were critical for the bacteriostatic synergistic effects of the triple combination. Selectively targeting CheA, SpvD, or MCR using the natural compound AS could be further investigated as an attractive strategy for the treatment of Salmonella infection. Collectively, our work opens new avenues toward the potentiation of COL and reveals an alternative drug combination strategy to overcome COL-resistant bacterial infections.

    1. Cell Biology
    Tamás Visnovitz, Dorina Lenzinger ... Edit I Buzas
    Short Report

    Recent studies showed an unexpected complexity of extracellular vesicle (EV) biogenesis pathways. We previously found evidence that human colorectal cancer cells in vivo release large multivesicular body-like structures en bloc. Here, we tested whether this large EV type is unique to colorectal cancer cells. We found that all cell types we studied (including different cell lines and cells in their original tissue environment) released multivesicular large EVs (MV-lEVs). We also demonstrated that upon spontaneous rupture of the limiting membrane of the MV-lEVs, their intraluminal vesicles (ILVs) escaped to the extracellular environment by a ‘torn bag mechanism’. We proved that the MV-lEVs were released by ectocytosis of amphisomes (hence, we termed them amphiectosomes). Both ILVs of amphiectosomes and small EVs separated from conditioned media were either exclusively CD63 or LC3B positive. According to our model, upon fusion of multivesicular bodies with autophagosomes, fragments of the autophagosomal inner membrane curl up to form LC3B positive ILVs of amphisomes, while CD63 positive small EVs are of multivesicular body origin. Our data suggest a novel common release mechanism for small EVs, distinct from the exocytosis of multivesicular bodies or amphisomes, as well as the small ectosome release pathway.